Nerman
Bearish
now
$NRXP This is an unfortunate case of breach of contract related to the development of a potentially life-saving COVID-19 treatment. NeuroRx and its CEO, Jonathan Javitt, have used threats, intimidation, and outright lies in an attempt to dodge their contractual commitments and extract as much money out of Relief as possible. The regrettable consequence of their actions has been to delay the global rollout of aviptadil – a drug which has shown great potential in mitigating the often-fatal acute respiratory distress syndrome caused by COVID-19
2
1